Leading the Way in Life Science Technologies

GEN Exclusives

More »

Insight & Intelligence™

Back to Item »

Myriad, Prometheus Continue to Defend Diagnostic Patents while Others Urge More Licensing

Battle raged on at second USPTO hearing tasked with evaluating the impact of patents on the availability of confirmatory tests.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »